Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2024European Journal of Medicinal Chemistry ReportsOpen Access

Design, synthesis, α-glucosidase inhibition and hypoglycemic activity of 3-aceto(benzo)hydrazide-1,2,4-triazines as potential anti-diabetic agents

View Full Paper
Ask AI
Bookmark
Share

Authors

MVMehdi ValipourZKZahra Zakeri KhatirKKKaveh Kiadaliry

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Valipour et al. (2024) studied this question.

synapsesocial.com/papers/68e5b288b6db64358754bc2dhttps://doi.org/10.1016/j.ejmcr.2024.100207
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis, biological activities, and molecular docking studies of triazolo[4,3‐<i>b</i>]triazine derivatives as a novel class of α‐glucosidase and α‐amylase inhibitors2024 · 15 citations
  2. 2Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents2024 · 10 citations
  3. 3Development of 1,2,3‐Triazoles as Dual Enzyme Inhibitors Targeting α‐Amylase and α‐Glucosidase for Type 2 Diabetes Intervention2025 · 3 citations
  4. 4Evaluation of the anti-diabetic activity of triaryl benzimidazole compounds, <i>in vitro</i> and molecular dynamic simulation study2026
  5. 5α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives2025